Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data.

Mrinalini DeyKatie BechmanSizheng ZhaoGeorge E FragoulisCatherine SmithAndrew CopeElena NikiphorouKimme L HyrichJames B Galloway

Published in: RMD open (2022)

Our findings show differences between drugs and can aid treatment decisions alongside real-world safety data. However, data are likely skewed by trial selection criteria and varying number of trials per drug and highlight the need for robust postmarketing pharmacovigilance.

Keyphrases

electronic health record
big data
drug induced
adverse drug
clinical trial
study protocol
randomized controlled trial
machine learning
data analysis
phase iii
artificial intelligence
phase ii
deep learning